 Home > Medical News > Latest Medical News > Boehringer Ingelheim and Thoeris collaborate on new treatments for urea cycle disorders

Boehringer Ingelheim and Thoeris collaborate on new treatments for urea cycle disorders

 Last Update: 2021-12-09
 Source: Internet
 Author: User

Tags

ian luebbers cause death

krokodil drug effects

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Boehringer Ingelheim will start a new collaboration with Thoeris to advance the first-of-its-kind therapy for the treatment of urea cycle disorders (UCD), regardless of the underlying single-gene cause.

Ingelheim, Germany and Vienna, Austria, November 3, 2021 /PRNewswire/ - Boehringer Ingelheim and Thoeris announced a collaboration and licensing agreement to study a new and first-of-its-kind treatment for urea cycle disorders (UCD)

"The new UCD treatment developed by Thoeris can detoxify excessive ammonia levels by promoting pathways in the body to control disease symptoms

“Strengthening emerging medical sciences to provide new therapies that change medical practice and improve the quality of life of patients is a key element of Boehringer Ingelheim’s strategy,” said Dr.

This collaboration stems from the commitment of the Boehringer Ingelheim Transboundary Research (RBB) team in the therapeutic field, which is the "innovation radar" of Boehringer Ingelheim's R&D department to explore unknown scientific fields

In patients with UCD, the absence or defect of one of several proteins involved in ammonia degradation will lead to hyperammonemia and the accumulation of toxic ammonia concentration in the body, which is related to acute pathological effects, such as cerebral edema, lethargy, neurological dysfunction and potential Death

Boehringer Ingelheim

Boehringer Ingelheim is committed to researching breakthrough therapies aimed at improving the health of humans and animals

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.